Exabis Library
Welcome to the e-CCO Library!
P617: Trends in Pediatric Inflammatory Bowel Disease-attributable direct costs: A Canadian population-based analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P618 Post-operative Crohn’s disease patients undergoing colonoscopy require significantly more analgesia and sedation compared with a non-IBD population
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P618: Long-term real-world data of Ustekinumab in Ulcerative Colitis – the Stockholm Ustekinumab study – STOCUSTE
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P618: Post-operative pain following laparoscopic right hemicolectomy for Crohn’s disease a comparative study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P618: Pre-operative oral enteral nutritional optimisation for Crohn’s disease: A retrospective UK tertiary IBD centre cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P618: Rapidity of onset of response to adalimumab in luminal Crohn's disease. Data from RAPIDA trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P618: Treatment outcomes of patients with Crohn’s disease and complex perianal fistula in five European countries: the PREFACE retrospective study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P618: Vedolizumab acute infusion reactions in inflammatory bowel disease patients: results of a multi-centre retrospective observational cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P619 Efficacy of zinc acetate hydrate administration for zinc deficiency in patients with inflammatory bowel disease: a multi-centre retrospective study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P619: Incidence of collagenous colitis in NHS Lothian: a population-based study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P619: Inflammatory bowel disease meets fertility: a physicians and patients survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P619: Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P619: Patterns of Anti-TNF Prescribing & Therapy Outcome in a Large Multicentre Cohort of Inflammatory Bowel Disease Patients
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P619: Systematic review: Psychosocial factors associated with pain in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P619: Tofacitinib for the treatment of resistant ulcerative colitis: the University of Chicago experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P620 Maintenance of clinical remission with SB5 biosimilar after switch from adalimumab originator: Real-life experience of a tertiary referral centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P620: Can ustekinumab trough and antidrug antibody levels post induction predict treatment failure?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P620: Differences in illness perceptions of Inflammatory Bowel Disease (IBD) between Healthcare Practitioners (HCPs) and patients in a UK tertiary IBD centre.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P620: Golimumab in ulcerative colitis: A multi-centre real-world experience
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P620: Network meta-analysis of efficacy and safety of different intravenous iron compounds for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM